PangenomeCOLN315NCTC8325NewmanUSA300_FPR375704-0298108BA0217611819-97685071193ECT-R 2ED133ED98HO 5096 0412JH1JH9JKD6008JKD6159LGA251M013MRSA252MSHR1132MSSA476MW2Mu3Mu50RF122ST398T0131TCH60TW20USA300_TCH1516VC40

⊟Summary

• pan ID^?: SAUPAN003285000
• symbol^?: purN
• synonym:
• description^?: phosphoribosylglycinamide formyltransferase

  descriptions from strain specific annotations:

  • phosphoribosylglycinamide formyltransferase
  • phosphoribosylglycinamide formyltransferase PurN
  • phosphoribosylformylglycinamidine formyltransferase
  • putative phosphoribosylglycinamide formyltransferase
• strand^?: +
• coordinates^?: 3660377..3660943
• synteny block^?: BlockID0023690
• occurrence^?: in 97% of 33 strains

⊟Orthologs

COL:
SACOL1081 (purN)
N315:
SA0924 (purN)
NCTC8325:
SAOUHSC_01016
Newman:
NWMN_0940 (purN)
USA300_FPR3757:
SAUSA300_0974 (purN)
04-02981:
SA2981_1028 (purN)
08BA02176:
C248_1097 (purN)
11819-97:
MS7_1030 (purN)
6850:
RSAU_000959 (purN)
71193:
ST398NM01_1070
ECT-R 2:
ECTR2_928 (purN)
ED133:
SAOV_1017
ED98:
SAAV_1037 (purN)
HO 5096 0412:
SAEMRSA15_09030 (purN)
JH1:
SaurJH1_1154
JH9:
SaurJH9_1132
JKD6008:
SAA6008_01028 (purN)
JKD6159:
SAA6159_00928 (purN)
LGA251:
SARLGA251_09860 (purN)
M013:
M013TW_1004
MRSA252:
SAR1046 (purN)
MSHR1132:
SAMSHR1132_09200
MSSA476:
SAS1008
Mu3:
SAHV_1064 (purN)
Mu50:
SAV1072 (purN)
MW2:
MW0955 (purN)
RF122:
SAB0939 (purN)
ST398:
SAPIG1070 (purN)
T0131:
SAT0131_01108
TCH60:
HMPREF0772_12161 (purN)
TW20:
SATW20_10680 (purN)
USA300_TCH1516:
—
VC40:
SAVC_04525

⊟Genome Viewer

COL
N315
NCTC8325
Newman
USA300_FPR3757

⊟Alignments

• alignment of orthologues:
  CLUSTAL format alignment by MAFFT L-INS-i (v7.307)
  
  
  COL             MVKIAIFASGSGSNFENIVEHVESGKLENIEVTALYTDHQNAFCIDRAKKHDIPVYINEP
  N315            MVKIAIFASGSGSNFENIVEHVESGKLENIEVTALYTDHQNAFCIDRAKKHDIPVYINEP
  NCTC8325        MVKIAIFASGSGSNFENIVEHVESGKLENIEVTALYTDHQNAFCIDRAKKHDIPVYINEP
  Newman          MVKIAIFASGSGSNFENIVEHVESGKLENIEVTALYTDHQNAFCIDRAKKHDIPVYINEP
  USA300_FPR3757  MVKIAIFASGSGSNFENIVEHVESGKLENIEVTALYTDHQNAFCIDRAKKHDIPVYINEP
                  ************************************************************
  
  COL             KQFDSKAAYEQHLVTLLNEDKVEWIILAGYMRLIGPDLLASFEGKILNIHPSLLPKYKGI
  N315            KQFDSKAAYEQHLVTLLNKDKVEWIILAGYMRLIGPDLLASFEGKILNIHPSLLPKYKGI
  NCTC8325        KQFDSKAAYEQHLVTLLNEDKVEWIILAGYMRLIGPDLLASFEGKILNIHPSLLPKYKGI
  Newman          KQFDSKAAYEQHLVTLLNEDKVEWIILAGYMRLIGPDLLASFEGKILNIHPSLLPKYKGI
  USA300_FPR3757  KQFDSKAAYEQHLVTLLNEDKVEWIILAGYMRLIGPDLLASFEGKILNIHPSLLPKYKGI
                  ******************:*****************************************
  
  COL             DAIGQAYHSGDTITGSTVHYVDSGMDTGEIIEQRKCDIRPDDSKEQLEEKVKKLEYELYP
  N315            DAIGQAYHSGDTITGSTVHYVDCGMDTGEIIEQRQCDIRPDDSKEQLEEKVKKLEYELYP
  NCTC8325        DAIGQAYHSGDTITGSTVHYVDSGMDTGEIIEQRKCDIRPDDSKEQLEEKVKKLEYELYP
  Newman          DAIGQAYHSGDTITGSTVHYVDSGMDTGEIIEQRKCDIRPDDSKEQLEEKVKKLEYELYP
  USA300_FPR3757  DAIGQAYHSGDTITGSTVHYVDSGMDTGEIIEQRKCDIRPDDSKEQLEEKVKKLEYELYP
                  **********************.***********:*************************
  
  COL             SVIAKIVK
  N315            SVIAKIVK
  NCTC8325        SVIAKIVK
  Newman          SVIAKIVK
  USA300_FPR3757  SVIAKIVK
                  ********